Our in-house experts have experience across the full cell and gene therapy life-cycle. Not only are they hard at work breaking down barriers to commercialise therapies, they are writing and sharing their knowledge through databases, publications, whitepapers, scientific posters and a host of other resources. Browse through the latest releases and contact us if there is a specific topic you would like to see covered.
16 January 2017
Development of a cost efficient platform for the industrial manufacturing of pluripotent stem cell derived products for cell therapy
04 January 2017
Requirement for smart in-process control systems to deliver cell therapy processes fit for the 21st century
12 December 2016
Cell and Gene Therapy Supply Chain - Challenge or Opportunity?